Formative-stage investor making $1–2.5M first checks targeting ≥5% equity in deep-health systems (biology, chemistry, AI/ML, robotics, clinical medicine), leveraging a private expert network that sources and vets deals. The firm continues to build its presence across the venture capital landscape.
Ranked by shared stages, industries, geography, cheque size and investor type. 400 related investors in the directory.
Backs early-phase life sciences businesses, often backing founders when they are no more than an idea.
Physician-led, immigrant-founded VC built by third-culture founders using cross-cultural insight to back healthcare founders with lived experience and target structural health inequities over generic digital tools. With a disciplined investment approach, the team drives value for both founders and investors.
Thesis-driven TechBio fund oriented toward engineering, computation, and biology, operating a BIOS community platform with podcasts, events, content, and a year-long Venture Residency training future TechBio VCs. Through targeted capital deployment, the fund plays an active role in the startup ecosystem.
Pre-seed specialist investing at the team and a dream stage in deep-tech applied AI and machine-centric businesses, using a proactive Frontier Curve framework organized around three vectors. Through targeted capital deployment, the fund plays an active role in the startup ecosystem.
Nascent-stage investor spanning service-heavy care delivery and deep neuro/bio/AR frontier tech, delivering specialized neuro+AI+delivery expertise that bridges physical clinics and cutting-edge technologies. With a disciplined investment approach, the team drives value for both founders and investors.
Seed and early-phase investor that creates and funds biotech young companies, emphasizing company creation. Through targeted capital deployment, the fund plays an active role in the startup ecosystem.
